Immunohistochemical evaluation of microsatellite instability in resected colorectal liver metastases: a preliminary experience
- 17 June 2020
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 37 (7) , 1-7
Abstract
In this retrospective study, we evaluated the predictive role of different immunohistochemical expression (IHC) of the mismatch repair proteins (MMR) in patients with colorectal liver metastasis (CRLM) submitted to liver resection. A total of 108 patients were retrieved, and 15 patients were excluded from the study because of the impossibility to obtain adequate formalin-fixed tissue blocks. The final analysis included 93 patients. Twenty-eight cases (30%) presented a no loss of expression or microsatellite stability (MSS) status, 59 cases (63%) showed a hybrid loss of expression, while 6 cases (7%) presented a complete loss of expression or microsatellite instability status (MSI). Patients with complete or hybrid loss of expression of MMR developed a high intra-hepatic recurrence rate compared to other ones (54% vs 21% OR of 4.278, 95% CI 1.53–11.93) (p = 0.004). The same difference in terms of liver recurrence has been found among patients with R0 resection (50% vs 17% OR of 0.2, 95% CI 0.06–0.65) (p = 0.005). However, there was no difference in terms of disease-free survival and overall survival. Complete or hybrid loss of expression of MMR could be considered a risk factor for intra-hepatic recurrences after liver resections for CRLM.Keywords
This publication has 14 references indexed in Scilit:
- Biomarkers in colorectal liver metastasesBritish Journal of Surgery, 2018
- Mechanisms of liver-induced toleranceCurrent Opinion in Organ Transplantation, 2017
- Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensusCancer Treatment Reviews, 2015
- Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection: a systematic review and meta-analysisInternational Journal of Colorectal Disease, 2015
- Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysisEuropean Journal of Cancer, 2015
- Moving Beyond Mindfulness: Defining Equanimity as an Outcome Measure in Meditation and Contemplative ResearchMindfulness, 2014
- The Liver-First Approach to the Management of Colorectal Cancer With Synchronous Hepatic MetastasesJAMA Surgery, 2013
- Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classificationJournal of Medical Genetics, 2012
- Microsatellite instability in colorectal cancer—the stable evidenceNature Reviews Clinical Oncology, 2010
- Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement By Abdalla et al. Editorial ReviewAnnals of Surgical Oncology, 2006